期刊文献+

含RGD肽基因导入系统介导TGFβ_1基因转染骨髓基质干细胞的瞬时表达与稳定表达 被引量:3

Transient Expression and Stable Expression of Rabbit Bone Marrow Stromal Cells Transfected with Transforming Growth Factor β_1 Gene Mediated with RGD-Containing Peptide Gene Delivery System in Vitro
暂未订购
导出
摘要 目的评价含RGD肽基因导入系统K16GRGDSPC(简记作K16-RGD)作为新型基因转染载体的可行性,并探讨转化生长因子β1(TGFβ1)基因转染骨髓基质干细胞(BMSCs)的表达能力。方法固相合成法合成K16-RGD。以6μgK16-RGD:2μgpcDNA3-TGFβ1(pTGFβ1)比例转染第三代兔BMSCs,转染72h后通过免疫组织化学染色和图像分析检测TGFβ1的瞬时表达水平;G418筛选2周形成阳性克隆,扩大培养后同法检测TGF-β1的稳定表达水平。通过酶联免疫吸附(ELISA)试剂盒检测TGF-β1的表达分析转染的量效关系和时效关系。结果瞬时转染组免疫组化部分细胞呈强阳性,稳定转染组几乎全部细胞呈强阳性并且持续表达4周以上。图像分析显示瞬时转染组和稳定转染组TGF-β1的表达均比对照组显著增强(P<0·01),且稳定表达组明显高于瞬时表达组(P<0·05)。ELISA法检测量效关系显示,转染体系中K16-RGD(μg)∶pTGFβ1(μg)为3∶1时TGFβ1有最高的表达效率;时效关系显示,稳定转染组TGFβ1的表达比瞬时表达组高(P<0·05)。结论含RGD肽基因导入系统K16-RGD作为基因转染载体是可行的,TGFβ1基因转染BMSCs可有效表达TGFβ1,为下一步利用K16-RGD作为载体构建载TGFβ1基因骨基质材料进行骨缺损修复研究奠定了基础。 Objective To evaluate the feasibility of K16GRGDSPC serving as a new vector for gene delivery and study the ability to express transforming growth factor βl gene of transduced rabbit bone marrow stromal cells in vitro. Methods The peptide was synthesized by solid- phase batch peptide synthesizer and characterized. The cultured 3rd generation rabbit bone marrow stromal cells (BMSCs) were transfected with the complexes of pcDNA3 - TGFβ1 (pTGFβ1) and peptide vector in the ratio of 1 to 3 in vitro. Immunohistochemistry staining and map analysis were performed to examine TGFβ1 gene expression. Enzyme- linked immuno- sorbent assay (ELISA) was performed to explore the dose- effect and time- effect relationship for higher gene transfection. Results Part cells of transient expression group and all cells of stable expression group showed strong positive activity for immunohitochemistry staining. TGFβ1 expression lasted more than 4 weeks. Map analysis indicated significant increase of TGFβ1 expression in BMSCs after gene transfer especially stable TGFβ1 gene transfer compared with control group. The gene transfection efficiency was highest when the proportion of pTGFβ1 to RGD peptide was 1 to 3 in mass. Conclusion RGD - containing peptide K16GRGDSPC can be used as a new kind of nonviral gene transfer vector. Transfected BMSCs can express active TGFβ1 effectively,which provides experimental foundations for further gene- modified bone tissue engineering study.
出处 《中国骨与关节损伤杂志》 2006年第9期717-719,共3页 Chinese Journal of Bone and Joint Injury
基金 国家自然科学基金项目(编号:30200063 30470483)
关键词 含RGD肽 TGFΒ1基因 转染 骨髓基质干细胞 RGD - containg peptide TGFβ1 gene Gene transfection Bone marrow stromal cells
  • 相关文献

参考文献6

  • 1Liu Y,Zheng QX,Du JY,et al.Clonging and expression of transforming growth factor βi in osteoblasts.J Tongji Med Univ,2000,20:63
  • 2Richard P,Harbottle,Robert G,et al.An RGD-oligolysine peptide:a prototype construct for interin-mediated gene delivery.Human Gene therapy,1998,9:1037
  • 3王运涛,郑启新,郭晓东,刘勇,李忠玉,吴永超.大鼠骨髓间充质干细胞的优化获取及生物学鉴定[J].华中科技大学学报(医学版),2003,32(5):526-529. 被引量:26
  • 4Collins L,Fabre JW.A synthetic peptide vector system for optimal gene delivery to corneal endothelium.J Gene Med.2004,6:185
  • 5Verrier S,Pallu S,Bareille R,et al.Function of linear and cyclic RGD-containing peptides in osteoproge-nitor cells adhesion process.Biomaterials,2002,23:585
  • 6李建军,杨绍娟,卜丽莎,高申,张文岚,崔亚南,王宏,刘建国,徐莘香.BMP-2基因转染的人骨髓基质干细胞复合PLA/PCL支架体外构建组织工程骨[J].骨与关节损伤杂志,2004,19(3):177-180. 被引量:13

二级参考文献20

  • 1Minguell J J, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med, 2001, 226:507.
  • 2Falla N, Van Vlasselaer P, Bierkens J et al. Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood, 1993, 82:3580.
  • 3Colter D C, Sekiya I, Prockop D J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA, 2001, 98:7841.
  • 4Deryugina E I, Muller-Sieburg C E. Stromal cells in long-term cultures: keys to the elucidation of hematopoietic development?. Crit Rew Immunol, 1993, 13:115.
  • 5Van Vlasselaer P, Falla N, Snoeck H. Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-sca-1 monoclonal antibody and wheat germ agglutinin. Blood, 1994, 84: 753.
  • 6Majumdar M K, Banks V, Peluso D Pet al. Isolation,characterization, and choni:lrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol, 2000, 185:98.
  • 7Pittenger M F, Mackay A M, Beck S C et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284: 143.
  • 8Cheng S L, Yang J W, Rifas I et al. Differentiation of human bone marrow osteogenic stromal cells in vitro:induction of the osteoblast phenotype by dexamethason.Endocrinology, 1994, 134:277.
  • 9Baltzer AWA, Lattermann C, Whalen JD, et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP - 2 gene. Gene Therapy, 2000,7:734.
  • 10Lieberman JR, Daluiski A, Stevenson S, et al. The effect of regional gene therapy with bone morphogenetic protein - 2 - producing bone- marrow cells on the repair of segmental femoral defects in rats.J Bone Joint Surg (Am), 1999, 81 (7): 905.

共引文献37

同被引文献23

  • 1李谷才,尹端沚,程登峰,王明伟,郑明强,汪勇先.4-[^(18)F]氟苯甲醛的放射化学合成[J].同位素,2006,19(2):87-91. 被引量:4
  • 2潘海涛,郑启新,郭晓东,刘勇,宋玉林.含RGD肽基因导入系统介导绿色荧光蛋白基因转染骨髓基质干细胞的瞬时表达检测[J].国际生物医学工程杂志,2006,29(3):129-131. 被引量:2
  • 3KIRSCH T, NICKEL J, SEBALD W. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor. BMPRII [J]. EMBOJ, 2000, 19(12)~ 3314-3324.
  • 4KIRSCH T, SEBALD W, DREYE M K. Crystal structure of the BMP-2-BRIA ectodomain complex[J].Nat Struct Biol, 2000, 7(6): 492-496.
  • 5SAITO A, SUZUKI Y, OGATA S I. Activation of osteoprogenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope [J]. Biochim Biophys Acta, 2003, 1651 (7): 60-67.
  • 6LIU Y, ZHENG Q X, DU J Y, et al. Cloning and expression of rat transforming growth factor 131 eDNA in osteoblasts[J]. J Tongji Med Univ,2000,20(1);63-65.
  • 7RICHARD P, HARBOTTLE M, ROBERT B, et al. An RGD-Oligolysine peptide: A prototype contrust for interin- mediated gene delivery [J].Human Gene Therapy, 1998, 9 (5) : 1045-1047.
  • 8TAKEZAWA T. A strategy for the development of tissue engineering scaffolds that regulate cell behavior [J]. Biomaterials,2003,24(13) : 2267-2275.
  • 9JADLOWIEC J A, CELIL A B, HOLLINGER J O. Bone tissue engineering: recent advances and promising therapeutic agents [J]. Expert Opin Biol Ther, 2003,3(2):409-423.
  • 10HENCH L, POLAK J. Third-generation biomedical material [J]. Science, 2002,295(6) :1014-1017.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部